TB-MBLA

Faster than current methods; more sensitive and specific than current standard of care

Culture-free method to accurately estimate viable (active) bacteria targeting a high copy number biomarker

Tuberculosis – pulmonary TB detection and treatment monitoring assay

No patents relating to the assay; however, know-how and technical design files to ISO13485